期刊
JOURNAL OF CLINICAL IMMUNOLOGY
卷 29, 期 3, 页码 257-264出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10875-009-9284-x
关键词
Plasmacytoid dendritic cells; type I interferon production; regulation of interferon responses; pDC development; CD4(+)CD56(+) hematodermic neoplasm
类别
资金
- National Institutes of Health
- M. D. Anderson Cancer Center
Plasmacytoid dendritic cells (pDCs) represent a unique and important immune cell population capable of producing large quantifies of type I interferon (IFN) in response to viruses as well as nucleic acid-containing complexes from the host. These rare and mysterious cells have been revealed by in-depth molecular characterization. Several innate sensors and signaling molecules enriched in pDCs allow their specialized innate immune functions. In addition, human pDCs use a group of surface receptors that, through activation of a B-cell receptor (BCR)-like signaling pathway, modulate type I IFN responses. It is clear now that pDC development is influenced by distinctive transcription factors that specify a unique lineage. CD4(+)CD56(+) hematodermic neoplasm of human pDC origin has been revealed in explicit molecular terms. A detailed molecular description of pDCs helps us better define, understand, and track human pDCs in relation to their functions and physiological involvement.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据